Based on above functions of GLP-1, liraglutide, as a GLP-1 long-lasting analogue, has been used for the treatment of T2DM, which, besides its well-known anti-diabetic properties, has been also recommended for the treatment of obesity [22]. This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.